Molecular diversity of HLA-A*02 in Asian Indians: predominance of A*0211

被引:53
作者
Mehra, N [1 ]
Jaini, R [1 ]
Rajalingam, R [1 ]
Balamurugan, A [1 ]
Kaur, G [1 ]
机构
[1] All India Inst Med Sci, Dept Histocompatibil & Immunogenet, New Delhi 110029, India
来源
TISSUE ANTIGENS | 2001年 / 57卷 / 06期
关键词
ARMS-PCR; HLA-A*0201; HLA-A*0211; reverse-blot; hybridization; selection pressure;
D O I
10.1034/j.1399-0039.2001.057006502.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The North Indians are considered predominantly Caucasoid with an admixture of genes from the Mongoloid and Aryan races. The present study was undertaken to investigate the genetic diversity of BLA-A*02 in the North Indian population and determine the frequency distribution of its molecular subtypes at the population level. The study revealed a high occurrence of A*0211 (33.8%) in this population along with increased frequencies of the common Oriental alleles, A*0206 (7.5%) and A*0207 (32.5%) and also of HLA-A*0205 (15%) commonly observed in negroid populations. HLA-A*0211 has only been reported with very low frequencies among the Ticuna Jews, Thai population, and Colombian Blacks in the malaria endemic areas of Africa. Significantly, we observed an unexpectedly low frequency of A*0201 (3.8%) in contrast to its distribution in Western Caucasians in whom it constitutes 95% of the HLA-A2 repertoire. Prevalence of HLA-A*0211 at very high frequencies among North Indians may be a consequence of the founder effect, racial admixture or selection pressure due to environmental factors in this population.
引用
收藏
页码:502 / 507
页数:6
相关论文
共 29 条
[21]   Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease [J].
Payami, H ;
Schellenberg, GD ;
Zareparsi, S ;
Kaye, J ;
Sexton, GJ ;
Head, MA ;
Matsuyama, SS ;
Jarvik, LF ;
Miller, B ;
McManus, DQ ;
Bird, TD ;
Katzman, R ;
Heston, L ;
Norman, D ;
Small, GW .
NEUROLOGY, 1997, 49 (02) :512-518
[22]   Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: Relevance for epitope specific vaccination protocols [J].
Player, MA ;
Barracchini, KC ;
Simonis, TB ;
Rivoltini, L ;
Arienti, F ;
Castelli, C ;
Mazzocchi, A ;
Belli, F ;
Parmiani, G ;
Marincola, FM .
JOURNAL OF IMMUNOTHERAPY, 1996, 19 (05) :357-363
[23]  
Rajalingam R., 1997, Indian Journal of Experimental Biology, V35, P1055
[24]  
Ressing ME, 1999, EUR J IMMUNOL, V29, P1292, DOI 10.1002/(SICI)1521-4141(199904)29:04<1292::AID-IMMU1292>3.0.CO
[25]  
2-6
[26]   Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions [J].
Sarobe, P ;
Pendleton, CD ;
Akatsuka, T ;
Lau, D ;
Engelhard, VH ;
Feinstone, SM ;
Berzofsky, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (06) :1239-1248
[27]   The HLA-A*0207 peptide binding repertoire is limited to a subset of the A*0201 repertoire [J].
Sidney, J ;
del Guercio, MF ;
Southwood, S ;
Hermanson, G ;
Maewal, A ;
Appella, E ;
Sette, A .
HUMAN IMMUNOLOGY, 1997, 58 (01) :12-20
[28]  
SUDO T, 1995, J IMMUNOL, V155, P4749
[29]  
1995, HLA AASTERISK02 SSP